Literature DB >> 15558323

Glucose stimulates the expression and activities of nitric oxide synthases in incubated rat islets: an effect counteracted by GLP-1 through the cyclic AMP/PKA pathway.

Javier Jimenez-Feltstrom1, Ingmar Lundquist, Albert Salehi.   

Abstract

We have examined the expression and activity of inducible nitric oxide synthase (iNOS) and the activity of neuronal constitutive NOS (ncNOS) in isolated rat pancreatic islets, stimulated by a "hyperglycaemic" concentration of glucose, and whether the NOS activities could be modulated by activation of the cyclic AMP/protein kinase A (cyclic AMP/PKA) system in relation to the insulin secretory process. Here, we show that glucose stimulation (20 mmol/l) induces iNOS and increases ncNOS activity. No iNOS is detectable at basal glucose levels (3.3 mmol/l). The addition of glucagon-like-peptide 1 (GLP-1) or dibutyryl-cAMP to islets incubated with 20 mmol/l glucose results in a marked suppression of iNOS expression and activity, a reduction in ncNOS activity and increased insulin release. The GLP-1-induced suppression of glucose-stimulated iNOS activity and expression and its stimulation of insulin release is, at least in part, PKA dependent, since the PKA inhibitor H-89 reverses the effects of GLP-1. These observations have been confirmed by confocal microscopy showing the glucose-stimulated expression of iNOS, its suppression by GLP-1 and its reversion by H-89 in beta-cells. We have also found that the NO scavenger cPTIO and the NOS inhibitor L-NAME potentiate the insulin response to glucose, again suggesting that NO is a negative modulator of glucose-stimulated insulin release. We conclude that the induction of iNOS and the increase in ncNOS activity caused by glucose in rat islets is suppressed by the cyclic AMP/PKA system. The inhibition of iNOS expression by the GLP-1/cyclic AMP/PKA pathway might possibly be of therapeutic potential in NO-mediated beta-cell dysfunction and destruction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15558323     DOI: 10.1007/s00441-004-1013-4

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  18 in total

1.  Inhibitory effect of UDP-glucose on cAMP generation and insulin secretion.

Authors:  Fariborz Parandeh; Stefan Amisten; Gaurav Verma; Israa Mohammed Al-Amily; Pontus Dunér; Albert Salehi
Journal:  J Biol Chem       Date:  2020-08-27       Impact factor: 5.157

2.  Reciprocal regulation between proinflammatory cytokine-induced inducible NO synthase (iNOS) and connexin43 in bladder smooth muscle cells.

Authors:  Kai Li; Jian Yao; Liye Shi; Norifumi Sawada; Yuan Chi; Qiaojing Yan; Hiroyuki Matsue; Masanori Kitamura; Masayuki Takeda
Journal:  J Biol Chem       Date:  2011-09-29       Impact factor: 5.157

3.  Glucose-modulated tyrosine nitration in beta cells: targets and consequences.

Authors:  Thomas Koeck; John A Corbett; John W Crabb; Dennis J Stuehr; Kulwant S Aulak
Journal:  Arch Biochem Biophys       Date:  2009-04-15       Impact factor: 4.013

4.  Modulation of regional nitric oxide metabolism: blood glucose control or insulin?

Authors:  Björn Ellger; Lies Langouche; Milan Richir; Yves Debaveye; Ilse Vanhorebeek; Tom Teerlink; Paul A Van Leeuwen; Greet Van den Berghe
Journal:  Intensive Care Med       Date:  2008-04-22       Impact factor: 17.440

5.  The role of nitric oxide synthase in post-operative hyperglycaemia.

Authors:  Ss Qader
Journal:  Libyan J Med       Date:  2008-09-01       Impact factor: 1.657

6.  Long-term fenofibrate treatment impaired glucose-stimulated insulin secretion and up-regulated pancreatic NF-kappa B and iNOS expression in monosodium glutamate-induced obese rats: is that a latent disadvantage?

Authors:  Shuai-nan Liu; Quan Liu; Lin-yi Li; Yi Huan; Su-juan Sun; Zhu-fang Shen
Journal:  J Transl Med       Date:  2011-10-14       Impact factor: 5.531

7.  Excessive islet NO generation in type 2 diabetic GK rats coincides with abnormal hormone secretion and is counteracted by GLP-1.

Authors:  Albert Salehi; Sandra Meidute Abaraviciene; Javier Jimenez-Feltstrom; Claes-Göran Ostenson; Suad Efendic; Ingmar Lundquist
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

8.  Palmitate-induced beta-cell dysfunction is associated with excessive NO production and is reversed by thiazolidinedione-mediated inhibition of GPR40 transduction mechanisms.

Authors:  Sandra Meidute Abaraviciene; Ingmar Lundquist; Juris Galvanovskis; Erik Flodgren; Björn Olde; Albert Salehi
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

9.  Characterisation of CART-containing neurons and cells in the porcine pancreas, gastro-intestinal tract, adrenal and thyroid glands.

Authors:  Nils Wierup; Anna Gunnarsdóttir; Eva Ekblad; Frank Sundler
Journal:  BMC Neurosci       Date:  2007-07-11       Impact factor: 3.288

10.  A Comparison of the Effects of the GLP-1 Analogue Liraglutide and Insulin Glargine on Endothelial Function and Metabolic Parameters: A Randomized, Controlled Trial Sapporo Athero-Incretin Study 2 (SAIS2).

Authors:  Hiroshi Nomoto; Hideaki Miyoshi; Tomoo Furumoto; Koji Oba; Hiroyuki Tsutsui; Arina Miyoshi; Takuma Kondo; Kenichi Tsuchida; Tatsuya Atsumi; Naoki Manda; Yoshio Kurihara; Shin Aoki
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.